QMS Medical reports Q2 and H1 FY2026 with revenue growth of 20% and 35% YoY, respectively, and steady EBITDA/PAT margins; highlights product expansion and Saarathi Healthcare integration.
AI Assistant
QMS Medical Allied Services Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.